NEW YORK, March 28, 2018 -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Welltower Inc. (NYSE:WELL), Integer Holdings Corporation (NYSE:ITGR), Jernigan Capital, Inc. (NYSE:JCAP), ZTO EXPRESS INC (NYSE:ZTO), Kala Pharmaceuticals, Inc. (NASDAQ:KALA), and Covenant Transportation Group, Inc. (NASDAQ:CVTI), including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.
Complimentary Access: Research Reports
Full copies of recently published reports are available to readers at the links below.
WELL DOWNLOAD: http://Fundamental-Markets.com/register/?so=WELL
ITGR DOWNLOAD: http://Fundamental-Markets.com/register/?so=ITGR
JCAP DOWNLOAD: http://Fundamental-Markets.com/register/?so=JCAP
ZTO DOWNLOAD: http://Fundamental-Markets.com/register/?so=ZTO
KALA DOWNLOAD: http://Fundamental-Markets.com/register/?so=KALA
CVTI DOWNLOAD: http://Fundamental-Markets.com/register/?so=CVTI
(You may have to copy and paste the link into your browser and hit the [ENTER] key)
The new research reports from Fundamental Markets, available for free download at the links above, examine Welltower Inc. (NYSE:WELL), Integer Holdings Corporation (NYSE:ITGR), Jernigan Capital, Inc. (NYSE:JCAP), ZTO EXPRESS INC (NYSE:ZTO), Kala Pharmaceuticals, Inc. (NASDAQ:KALA), and Covenant Transportation Group, Inc. (NASDAQ:CVTI) on a fundamental level and outlines the overall demand for their products and services in addition to an in-depth review of the business strategy, management discussion, and overall direction going forward. Several excerpts from the recently released reports are available to today's readers below.
-----------------------------------------
Important Notice: the following excerpts are not designed to be standalone summaries and as such, important information may be missing from these samples. Please download the entire research report, free of charge, to ensure you are reading all relevant material information. All information in this release was accessed March 26th, 2018. Percentage calculations are performed after rounding. All amounts in millions (MM), except per share amounts.
-----------------------------------------
WELLTOWER INC. (WELL) REPORT OVERVIEW
Welltower's Recent Financial Performance
For the three months ended December 31st, 2017 vs December 31st, 2016, Welltower reported revenue of $1,104.26MM vs $1,078.32MM (up 2.41%) and basic earnings per share -$0.31 vs $0.93. For the twelve months ended December 31st, 2017 vs December 31st, 2016, Welltower reported revenue of $4,316.64MM vs $4,281.16MM (up 0.83%) and basic earnings per share $1.26 vs $2.83 (down 55.48%). Welltower is expected to report earnings on May 4th, 2018. The report will be for the fiscal period ending March 31st, 2018. The reported EPS for the same quarter last year was $1.05. The estimated EPS forecast for the next fiscal year is $4.18 and is expected to report on February 28th, 2019.
To read the full Welltower Inc. (WELL) report, download it here: http://Fundamental-Markets.com/register/?so=WELL
-----------------------------------------
INTEGER HOLDINGS CORPORATION (ITGR) REPORT OVERVIEW
Integer's Recent Financial Performance
For the three months ended December 31st, 2017 vs December 31st, 2016, Integer reported revenue of $390.48MM vs $359.59MM (up 8.59%) and basic earnings per share $1.73 vs $0.26 (up 565.38%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, Integer reported revenue of $1,461.92MM vs $1,386.78MM (up 5.42%) and basic earnings per share $2.12 vs $0.19 (up 1,015.79%). Integer is expected to report earnings on May 14th, 2018. The report will be for the fiscal period ending March 31st, 2018. The reported EPS for the same quarter last year was $0.41. The estimated EPS forecast for the next fiscal year is $3.77 and is expected to report on February 28th, 2019.
To read the full Integer Holdings Corporation (ITGR) report, download it here: http://Fundamental-Markets.com/register/?so=ITGR
-----------------------------------------
JERNIGAN CAPITAL, INC. (JCAP) REPORT OVERVIEW
Jernigan Capital's Recent Financial Performance
For the three months ended December 31st, 2017 vs December 31st, 2016, Jernigan Capital reported revenue of $3.93MM vs $2.16MM (up 82.11%) and basic earnings per share $0.17 vs $0.51 (down 66.67%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, Jernigan Capital reported revenue of $12.19MM vs $6.53MM (up 86.64%) and basic earnings per share $1.10 vs $2.42 (down 54.55%). Jernigan Capital is expected to report earnings on May 2nd, 2018. The report will be for the fiscal period ending March 31st, 2018. The reported EPS for the same quarter last year was $0.12. The estimated EPS forecast for the next fiscal year is $2.28 and is expected to report on February 27th, 2019.
To read the full Jernigan Capital, Inc. (JCAP) report, download it here: http://Fundamental-Markets.com/register/?so=JCAP
-----------------------------------------
ZTO EXPRESS INC (ZTO) REPORT OVERVIEW
ZTO EXPRESS INC's Recent Financial Performance
For the three months ended September 30th, 2017 vs September 30th, 2016, ZTO EXPRESS INC reported revenue of $472.41MM vs $352.86MM (up 33.88%) and basic earnings per share $0.15 vs $0.12 (up 25.00%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, ZTO EXPRESS INC reported revenue of $2,007.30MM vs $1,409.88MM (up 42.37%) and basic earnings per share $0.68 vs $0.42 (up 61.90%). ZTO EXPRESS INC is expected to report earnings on May 16th, 2018. The report will be for the fiscal period ending March 31st, 2018. The reported EPS for the same quarter last year was $0.10. The estimated EPS forecast for the next fiscal year is $1.06 and is expected to report on March 4th, 2019.
To read the full ZTO EXPRESS INC (ZTO) report, download it here: http://Fundamental-Markets.com/register/?so=ZTO
-----------------------------------------
KALA PHARMACEUTICALS, INC. (KALA) REPORT OVERVIEW
Kala Pharmaceuticals' Recent Financial Performance
Kala Pharmaceuticals is expected to report earnings on June 25th, 2018. The report will be for the fiscal period ending March 31st, 2018. The estimated EPS forecast for the next fiscal year is -$2.60 and is expected to report on March 25th, 2019.
To read the full Kala Pharmaceuticals, Inc. (KALA) report, download it here: http://Fundamental-Markets.com/register/?so=KALA
-----------------------------------------
COVENANT TRANSPORTATION GROUP, INC. (CVTI) REPORT OVERVIEW
Covenant Transportation Group's Recent Financial Performance
For the three months ended December 31st, 2017 vs December 31st, 2016, Covenant Transportation Group reported revenue of $203.31MM vs $190.98MM (up 6.46%) and basic earnings per share $2.70 vs $0.33 (up 718.18%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, Covenant Transportation Group reported revenue of $705.01MM vs $670.65MM (up 5.12%) and basic earnings per share $3.03 vs $0.93 (up 225.81%). Covenant Transportation Group is expected to report earnings on April 19th, 2018. The report will be for the fiscal period ending March 31st, 2018. The reported EPS for the same quarter last year was $0.03. The estimated EPS forecast for the next fiscal year is $2.22 and is expected to report on February 4th, 2019.
To read the full Covenant Transportation Group, Inc. (CVTI) report, download it here: http://Fundamental-Markets.com/register/?so=CVTI
-----------------------------------------
ABOUT FUNDAMENTAL MARKETS
Fundamental Markets serves thousands of members and have provided research through some of the world's leading brokerages for over a decade–and continue to be one of the best information sources for investors and investment professionals worldwide. Fundamental Markets' roster boasts decades of financial experience and includes top financial writers, FINRA® BrokerCheck® certified professionals with current and valid CRD® number designations, as well as Chartered Financial Analyst® (CFA®) designation holders, to ensure up to date factual information for active readers on the topics they care about.
REGISTERED MEMBER STATUS
Fundamental Markets' oversight and audit staff are registered analysts, brokers, and/or financial advisers ("Registered Members") working within Equity Research, Media, and Compliance departments. Fundamental Markets' roster includes qualified CFA® charterholders, licensed securities attorneys, and registered FINRA® members holding duly issued CRD® numbers. Current licensed status of several Registered Members at Fundamental Markets have been independently verified by an outside audit firm, including policy and audit records duly executed by Registered Members. Complaints, concerns, questions, or inquiries regarding this release should be directed to Fundamental Markets' Compliance department by Phone, at +1 667-401-0010, or by E-mail at [email protected].
LEGAL NOTICES
Information contained herein is not an offer or solicitation to buy, hold, or sell any security. Fundamental Markets, Fundamental Markets members, and/or Fundamental Markets affiliates are not responsible for any gains or losses that result from the opinions expressed. Fundamental Markets makes no representations as to the completeness, accuracy, or timeliness of the material provided and all materials are subject to change without notice. Fundamental Markets has not been compensated for the publication of this press release by any of the above mentioned companies. Fundamental Markets is not a financial advisory firm, investment adviser, or broker-dealer, and does not undertake any activities that would require such registration. For our full disclaimer, disclosure, and terms of service please visit our website.
Media Contact:
Andrew Duffie, Media Department
Office: +1 667-401-0010
E-mail: [email protected]
© 2018 Fundamental Markets. All Rights Reserved. For republishing permissions, please contact a partner network manager at [email protected].
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
FINRA®, BrokerCheck®, and CRD® are registered trademarks owned by Financial Industry Regulatory Authority, Inc.


Chery Invests $75 Million in KG Mobility to Expand Global Automotive Partnership
Heineken H1 Operating Profit Meets Forecast as Beer Volumes Beat Expectations
FleetPartners Shares Jump After A$760 Million Takeover Proposal From Pacific Equity Partners
UK AI Security Tests Reveal Anthropic and OpenAI Agents Attempted Unauthorized Actions
Shein Targets $30B-$40B Valuation in Hong Kong IPO Planned for August
Glencore Posts Strong H1 2026 Earnings, Announces ASX Secondary Listing
HSBC H1 Profit Jumps 23%, Announces $1 Billion Share Buyback and Reaffirms 2028 Targets
Novo Nordisk Eyes Turnaround as Oral Wegovy Challenges Eli Lilly in Weight-Loss Drug Race
Samsung, SK Hynix Test AMEC Chipmaking Tools for China Backup Plan
Alibaba Stock Jumps as Qwen 3.8-MAX AI Model Intensifies China's AI Race
Novo Nordisk Raises 2025 Outlook Despite Wegovy Pill Miss and CagriSema Setback
Toyota Raises FY2027 Outlook, Announces ¥1 Trillion Buyback Despite Q1 Profit Dip
SK Hynix Bonus Dispute Deepens as Union Rejects Stock-Based Payout Proposal
Infineon Raises 2026 Revenue Outlook as AI Data Center Demand Fuels Record Quarterly Sales
SpaceX Earnings Preview: Bernstein Says 4 Key Factors Will Drive Long-Term Valuation
Jetstar to Charge for Overhead Cabin Bags From February
Trump Urges Exxon, Chevron to Cut Gas Prices After Record Oil Profits 



